Metallotherapeutic Drugs and Metal‐Based Diagnostic Agents 2005
DOI: 10.1002/0470864052.ch4
|View full text |Cite
|
Sign up to set email alerts
|

13 Al Aluminum Metallotherapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…[16][17][18][19][20] The rst investigation of the antimicrobial action of gallium was published in 1931. 21 It has been reported that gallium (Ga 3+ ) exerts a signicant inhibitory activity against numerous bacteria including Staphylococcus aureus, methicillin-resistant S. aureus, Rhodococcus equi, Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli. [22][23][24][25][26] , in the form of Ga(NO 3 ) 3 solution (Ganite; Genta), is already FDA approved and given in large doses (i.v.)…”
mentioning
confidence: 99%
“…[16][17][18][19][20] The rst investigation of the antimicrobial action of gallium was published in 1931. 21 It has been reported that gallium (Ga 3+ ) exerts a signicant inhibitory activity against numerous bacteria including Staphylococcus aureus, methicillin-resistant S. aureus, Rhodococcus equi, Pseudomonas aeruginosa, Acinetobacter baumannii and Escherichia coli. [22][23][24][25][26] , in the form of Ga(NO 3 ) 3 solution (Ganite; Genta), is already FDA approved and given in large doses (i.v.)…”
mentioning
confidence: 99%